Influenza A virus replication is inhibited in IFN-λ2 and IFN-λ3 transfected or stimulated cells

Antiviral Research

Volumn 88, Issue 3, 2010, Pages 329-333

  Svetlikova, Darina ^a   Kabat, Peter ^a,c   Ohradanova, Anna ^a,c   Pastorek, Jaromir ^a   Betakova, Tatiana ^a,b  

^a INSTITUTE OF VIROLOGY   (Slovakia)

^b Centre for Molecular Medicine   (Slovakia)

^c Faculty of Natural Sciences   (Slovakia)

Author keywords

Cytokines; Influenza virus; Interferon; Interleukin

Indexed keywords

INTERFERON; INTERFERON LAMBDA 2; INTERFERON LAMBDA 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL STIMULATION; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VERO CELL; VIRUS INHIBITION; VIRUS PLAQUE; VIRUS REPLICATION;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 78649486597     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.10.005     Document Type: Article

References (30)

1. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
2. Au W.C., Yeow W.S., Pitha P.M. Analysis of functional domains of interferon regulatory factor 7 and its association with IRF-3. Virology 2001, 280:273-282.
3. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., Lanzavecchia A. Maturation, activation and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 1999, 189:821-829.
4. Cella M., Facchetti F., Lanzavecchia A., Colonna M. Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 2000, 1:305-310.
5. Coccia E.M., Severa M., Giacomini E., Monneron D., Remoli M.E., Julkunen I., Cella M., Lande R., Uzé G. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 2004, 34:796-805.
6. Dumoutier L., Tounsi A., Michiels T., Sommereyns C., Kotenko S.V., Renauld J.C. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signalling. J. Biol. Chem. 2004, 279:32269-32274.
7. Emeny J.M., Morgan M.J. Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J. Gen. Virol. 1979, 43:247-252.
8. Emeny J.M., Morgan M.J. Susceptibility of various cells treated with interferon to the toxic effect of poly(rI).poly(rC) treatment. J. Gen. Virol. 1979, 43:253-255.
9. Files J.G., Gray J.L., Do L.T., Foley W.P., Gabe J.D., Nestaas E., Pungor E. A novel sensitive and selective bioassay for human type I interferons. J. Interferon Cytokine Res. 1998, 18:1019-1024.
10. Hay A.J., Wolstenholme A.J., Skehel J.J., Smith M.H. The molecular basis of the specific anti-influenza action of amantadine. EMBO J 1985, 4:3021-3024.
11. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., Horiuchi T., Tomizawa H., Takeda K., Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002, 3:196-200.
12. Ihle J., Kerr I. JAKS and STATs in signaling by the cytokine superfamily. Trends Genet. 1995, 11:69-74.
13. Julkunen I., Melén K., Nyqvist M., Pirhonen J., Sareneva T., Matikainen S. Inflammatory responses in influenza A virus infection. Vaccine 2000, 19:S32-S37.
14. Kotenko S.V., Gallagher G., Baurin V.V., Lewis-Antes A., Shen M., Shah N.K., Langer J.A., Sheikh F., Dickensheets H., Donnelly R.P. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 2003, 4:69-77.
15. Matikainen S., Pirhonen J., Miettinen M., Lehtonen A., Govenius-Vintola C., Sareneva T., Julkunen I. Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. Virology 2000, 276:138-147.
16. Matikainen S., Paananen A., Miettinen M., Kurimoto M., Timonen T., Julkunen I., Sareneva T. IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12. Eur. J. Immunol. 2001, 31:2236-2245.
17. Meager A., Visvalingam K., Dilger P., Bryan D., Wadhwa M. Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 2005, 31:109-118.
18. Noah D.L., Twu K.Y., Krug R.M. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS. Virology 2003, 307:386-395.
19. Osterlund P., Veckman V., Sirén J., Klucher K.M., Hiscott J., Matikainen S., Julkunen I. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells. J. Virol. 2005, 79:9608-9617.
20. Pestka S., Krause C.D., Walter M.R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 2004, 202:8-32.
21. Pirhonen J., Sareneva T., Kurimoto M., Julkunen I., Matikainen S. Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. J. Immunol. 1999, 162:7322-7329.
22. Pirhonen J., Matikainen S., Julkunen I. Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J. Immunol. 2002, 169:5673-5678.
23. Ronni T., Sareneva T., Pirhonen J., Julkunen I. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J. Immunol. 1995, 154:2764-2774.
24. Sareneva T., Matikainen S., Kurimoto M., Julkunen I. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J. Immunol. 1998, 160:6032-6038.
25. Sareneva T., Julkunen I., Matikainen S. IFN-alpha and IL-12 induce IL-18 receptor gene expression in human NK and T cells. J. Immunol. 2000, 165:1933-1938.
26. Sheppard P., Kindsvogel W., Xu W., Henderson K., Schlutsmeyer S., Whitmore T.E., Kuestner R., Garrigues U., Birks C., Roraback J., Ostrander C., Dong D., Shin J., Presnell S., Fox B., Haldeman B., Cooper E., Taft D., Gilbert T., Grant F.J., Tackett M., Krivan W., McKnight G., Clegg C., Foster D., Klucher K.M. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 2003, 4:63-68.
27. Talon J., Horvath C.M., Polley R., Basler C.F., Muster T., Palese P., García-Sastre A. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J. Virol. 2000, 74:7989-7996.
28. Veckman V., Osterlund P., Fagerlund R., Melén K., Matikainen S., Julkunen I. TNF-alpha and IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology 2006, 345:96-104.
29. Wang J., Oberley-Deegan R., Wang S., Nikrad M., Funk C.J., Hartshorn K.L., Mason R.J. Differentiated human alveolar type II cells secrete antiviral IL-29 (IFN-lambda 1) in response to influenza A infection. J. Immunol. 2009, 182:1296-1304.
30. Yeldandi A.V., Colby T.V. Pathologic features of lung biopsy specimens from influenza pneumonia cases. Hum. Pathol. 1994, 25:47-53.